Navigation Links
Bio-Research Products Introduces New Grade of Chloroperoxidase Enzyme for Industrial Applications
Date:10/20/2010

NORTH LIBERTY, Iowa, Oct. 20 /PRNewswire/ -- Bio-Research Products announced today that it will add to its Chloroperoxidase (CPO) offerings a lower cost, industrial grade for application to organic syntheses such as oxidations and halogenations. Dr. Bryce Cunningham, President, said that "there has been an increased interest in CPO from industrial and pharmaceutical markets which has prompted us to establish a grade that better meets their needs."

(Logo: http://photos.prnewswire.com/prnh/20101020/CG84900LOGO)

(Logo: http://www.newscom.com/cgi-bin/prnh/20101020/CG84900LOGO)

Dr. Harold Durkin, Business Development Manager, describes Chloroperoxidase as a catalyst for oxidation of alcohols and double bonds that allows these reactions to proceed at room temperature to high yields without by-products. "This catalyst fits in well with the green chemistry movement and should be of particular interest to the fragrance industry where oxidation of primary alcohols to aldehydes is a key route to aroma chemicals."

The new industrial grade of liquid Chloroperoxidase is designated as Catalog #502 and has an Rz value of ~1.2 and a price of $7.50 per KU in gram quantities. Bio-Research Products already markets a liquid CPO (#501) and a lyo CPO (#503). Bio-Research Products' CPO enzyme is derived from Caldariomyces fumago.

Bio-Research Products also produces industrial grades of its Soybean Peroxidase (SBP) enzyme. SBP #514 (liquid) is useful for the polymerization of conductive polymers such as polyaniline and SBP #X516-IND (powder) is offered for the bioremediation of waste water and manure odors.

For a free sample and/or product data sheet for Chloroperoxidase #502, or to discuss your catalyst needs, please contact us by phone at 800-326-3511 or by email: bryce@bio-researchprod.com.


'/>"/>
SOURCE Bio-Research Products
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. China Biologic Products Announces Second Quarter 2008 Results Conference Call
2. China Biologic Products Establishes Governance and Nominating Committee and Compensation Committee
3. China Biologic Products Reports Second Quarter 2008 Results
4. DuPont Obtains Biotechnology Endorsement for Pioneer(R) Brand Products
5. New nanotechnology centre helps turn big ideas into real products
6. Expression Genetics EGEN-001 Named One of 10 Most Promising Oncology Products by Windhover
7. China Biologic Products to Present at the SIG Beijing Management Summit
8. Biotechnology & Drug Discovery Markets Push Up Demand for Lab Automation Products, According to a New Report by Global Industry Analysts
9. Varian Medical Systems Exhibits a New Version of RapidArc(TM) Radiotherapy Technology and Other Products for Fast, Precise Cancer Treatment
10. Martek is Now the Sole-Source Supplier of ARA for all Infant Formula Products Manufactured by Hochdorf Nutricare
11. Gores Legacy of Innovation Extends From Products to Processes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/23/2017)... , March 23, 2017 ... at four equities in the Biotech industry: Sangamo Therapeutics ... Biologics Inc. (NYSE MKT: SYN), and Regulus Therapeutics Inc. ... st , 2017, Credit Suisse upgraded its rating on Pharmaceuticals/Biotechnology ... downloading their free report at: ...
(Date:3/22/2017)... SANTA MONICA, Calif. , March 22, 2017 ... Council (MassMEDIC) are proud to announce their extended partnership ... Week will be headlined by the 21 st ... UBM,s BIOMEDevice Boston, taking place May 3-4, 2017. ... with Advanced Medical Technology Association (ADVAMED) President and ...
(Date:3/22/2017)... , March 22, 2017 MarketNewsUpdates.com News ... ... conditions are being pressured as of late due to the ... pain management has a dramatic impact on patient,s quality of ... development activities for identifying new forms of opioid formulations that ...
(Date:3/22/2017)... ... March 21, 2017 , ... Okyanos Cell Therapy has announced ... of their live events series, “Stem Cell Therapy: The Next Phase in the Evolution ... 2013 Stem Cell Research and Therapy Act, Okyanos maintains a mission to ...
Breaking Biology Technology:
(Date:2/10/2017)... 2017 Research and Markets has ... Medicine - Scientific and Commercial Aspects" to their offering. ... ... integrated with therapy for selection of treatment as well for ... prevention of disease in modern medicine. Biochip/microarray technologies and next ...
(Date:2/8/2017)... NEW YORK , Feb. 8, 2017 /PRNewswire/ ... an individual,s voice to match it against a ... voice such as pitch, cadence, and tone are ... systems require minimal hardware installation, as most PCs ... remotely for different transactions. Voice recognition biometrics are ...
(Date:2/8/2017)... , Feb. 7, 2017 Report Highlights ... The global ... reach $11.4 billion by 2021, growing at a compound annual ... - An overview of the global markets for synthetic biology. ... estimates for 2016, and projections of compound annual growth rates ...
Breaking Biology News(10 mins):